Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2012-01-18 Board/Management Inform…
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
JAMES ORCHARD RESIGNATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, specifically reporting the resignation of a board member, James Orchard, from the company's Board of Directors. The key section is ITEM 5.02, which relates to departure of certain officers and election or appointment of directors or officers. There is no financial data or report content, only an announcement of a management change. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is short and focused solely on this management change, confirming the classification as MANG.
2012-01-18 English
FORM RW S-1 WITHDRAWL
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to the SEC requesting withdrawal of a previously filed Registration Statement on Form S-1. It references Rule 477 under the Securities Act of 1933 and explicitly states the withdrawal of the Registration Statement has not been declared effective and no securities were sold. The content is regulatory in nature, concerning a filing withdrawal, and does not contain financial data or report content. The document length is short (1825 characters), and it is clearly an official regulatory communication rather than a financial report or announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS).
2012-01-12 English
SHAHEEN JUDGEMENT FORM 8-K
Legal Proceedings Report Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically reports a legal judgment against the company in a litigation case (Shaheen v. Ecology Coatings, Inc.). There are no financial statements or exhibits attached, and the document is brief (2319 characters). This fits the category of a Legal Proceedings Report, as it updates on significant lawsuits involving the company. It is not an Annual Report, Earnings Release, or any other financial report. Therefore, the correct classification is Legal Proceedings Report (LTR).
2012-01-03 English
AMENDMENT NO. 1 OF FISCAL YEAR 2011 FORM 10-K
Annual Report FY 2011
2011-12-28 English
SALLY RAMSEY EMPLOYMENT AGREEMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing with the SEC, dated December 22, 2011, reporting the entry into a material definitive agreement, specifically an employment agreement with a named executive. The content focuses on the terms of the employment agreement for a Vice President, including salary and termination conditions. There are no financial statements or quarterly/yearly financial results presented. The document is not an annual or interim report, earnings release, or investor presentation. It is a current report disclosing a material event related to management employment terms. This fits the category of Regulatory Filings (RNS), which covers miscellaneous filings that do not fit other specific categories, including employment agreements disclosed via Form 8-K.
2011-12-22 English
FISCAL YEAR 2011 FORM 10-K
Annual Report FY 2011
2011-12-16 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.